Dr. Chen Honglin, director of the Primary Diabetes Association and dean of the open clinic, explained that high blood sugar can cause inflammation, coupled with poor control of blood pressure and blood lipids, and finally blood vessels may cause various vascular complications such as atherosclerosis. As long as sugar friends can control their blood pressure below 140/80 mm Hg; Glycosylated hemoglobin below 7.0, blood lipid 100mg/dL below. In the case of regular exercise and follow-up, the cardiovascular risk is actually the same as that of people without diabetes.
Approved by the American Medical Association! Drug control and blood sugar control of new-onset diabetes can also take care of both heart and kidney.
In addition to eating patterns and living habits, the prevention of heart nephropathy can actually change from passive to active. In recent years, a series of large-scale research reports have pointed out that SGLT2 inhibitor (type 2 sodium-glucose transporter inhibitor), a hypoglycemic drug for type 2 diabetes mellitus, can not only lower blood sugar, but also take into account the risk of cardiac nephropathy.
Dr. Chen Honglin pointed out that in 2020, both the American Diabetes Association and the American Society of Clinical Endocrinology emphasized that in the process of treating diabetes, if patients have cardiovascular risk, early use of GLP- 1 (glucagon-like peptide) or SGLT2 inhibitors can not only control blood sugar, but also protect the heart, kidneys and blood vessels. Especially when the patient's renal function is still good, he starts to take medicine, and the help he gets is the best.
However, SGLT2i excretes sugar through urine, which may increase the risk of urinary tract infection. Be sure to bring enough water when using, don't hold your urine, and pay attention to the cleanliness of private parts when going to the toilet. GLP‐ 1 may produce side effects such as nausea, vomiting and diarrhea. When seeing a doctor, sugar friends should discuss personal disease control goals with the doctor. If there are any related problems during the treatment, the doctor should make adjustments according to professional judgment, and the drug should not be stopped without authorization.
Primary clinics help control sugar and weave diabetes.
In the past, many sugar friends chose to go back to big hospitals for treatment, but they were discouraged because of the outbreak of the epidemic. In fact, since 1996, Fu Weibu has introduced the concept of diabetes care network, and many grassroots clinics have participated in it. During the epidemic, patients are strictly controlled, so that sugar friends can feel at ease and receive complete care.
Dr. Chen said that * * * has a clear framework and guidelines with the nursing network. As long as the patients have regular follow-up, follow-up, diagnosis and treatment, and adjustment, they can get the greatest benefits. Many primary clinics are equipped with professional teams: besides doctors, there are nutritionists and nursing teachers. And they can also do fundus examination, arteriosclerosis and other examinations. When necessary, they will refer patients to departments related to chronic diseases, such as nephrology, ophthalmology and cardiology, to bring the most complete care to sugar friends.
The current epidemic situation, drugs deployed in advance, no accident! Xu Yitang has peace of mind.
The COVID-19 epidemic may affect the API production line, but doctors said that most of the original drugs are still in sufficient supply, and various medical institutions have deployed them in advance. Therefore, I appeal to sugar friends not to worry, to find a clinic for daily care and a hospital for severe needs. As long as sugar friends are assured to control sugar, they should pay attention to the symptoms of cardiovascular and renal complications, avoid emergencies, take care of themselves, reduce the burden on medical staff and do their part for epidemic prevention.
Dr. Chen Honglin pointed out that in 2020, both the American Diabetes Association and the American Society of Clinical Endocrinology emphasized that in the process of treating diabetes, if patients have cardiovascular risk, early use of GLP- 1 (glucagon-like peptide) or SGLT2 inhibitors can not only control blood sugar, but also protect the heart, kidneys and blood vessels.
Join us and pay attention to your health every day! Line @ ID: @ Subscribe to the health ALOHO audio-visual channel to read health knowledge more easily: /supply/article/45774 Keywords: Chen Honglin, type 2 diabetes, SGLT2 inhibitor, diabetes care network, sugar control, cardiac and renal complications.